Q3 2017 Holdings
Filed 2017-11-14 | 139 holdings | $314.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-11-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals(ALNY) | COM | 02043Q107 | $210.2M | 1,788,802 | 66.8% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $32.1M | 1,630,000 | 10.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $25.3M | 1,390,381 | 8.0% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $22.2M | 3,085,458 | 7.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $10.1M | 450,000 | 3.2% |
| Ardelyx Inc(ARDX)A | COM | 039697107 | $7.6M | 1,352,391 | 2.4% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $2.2M | 721,102 | 0.7% |
| Champions Oncology Inc(CSBR) | COM | 15870P307 | $1.4M | 386,540 | 0.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $642.0K | 3,448 | 0.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $590.0K | 5,700 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $293.6K | 4,791,589 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $269.8K | 17,888,597 | 0.1% |
| Global Blood Therapeutics in | COM | 37890U108 | $132.4K | 4,264,066 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $128.6K | 3,670,357 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $110.6K | 923,820 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR.0001 2 | 503459604 | $75.0K | 2,157,011 | 0.0% |
| Retrophin Inc | COM | 761299106 | $66.9K | 2,686,204 | 0.0% |
| Avexis Inc | COM | 05366U100 | $64.9K | 671,181 | 0.0% |
| Corium Intl Inc | COM | 21887L107 | $64.8K | 5,847,133 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $60.3K | 1,616,259 | 0.0% |
| Tesaro Inc | COM | 881569107 | $50.2K | 388,651 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $47.5K | 1,441,186 | 0.0% |
| Dova Pharmaceuticals Inc(DOVA) | COM | 25985T102 | $42.6K | 1,754,015 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $36.6K | 4,726,114 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $34.9K | 1,264,523 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $34.3K | 982,269 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $29.6K | 1,293,095 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $29.6K | 424,661 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $26.4K | 25,195 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $25.3K | 6,565,843 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $24.5K | 576,419 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $24.4K | 100,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $23.6K | 550,717 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $21.9K | 781,309 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $21.2K | 1,162,325 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $21.1K | 138,626 | 0.0% |
| Galapagos N V(GLPG) | SPON ADR | 36315X101 | $21.0K | 206,405 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $19.3K | 372,671 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $18.9K | 2,350,882 | 0.0% |
| Quotient Technology Inc | COM | G73268107 | $18.4K | 3,726,986 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $17.7K | 845,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $17.7K | 1,884,500 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $17.4K | 5,185,847 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $16.3K | 1,549,005 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $16.0K | 180,000 | 0.0% |
| Abeona Therapeutics Inc | *W EXP 12/24/201 | 00289Y115 | $15.8K | 1,259,636 | 0.0% |
| Alliqua Biomedical Inc | COM NEW | 019621200 | $15.5K | 4,233,951 | 0.0% |
| Assembly Biosciences Inc | COM | 045396108 | $15.4K | 441,833 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $15.1K | 850,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $14.7K | 929,460 | 0.0% |